News
Balancing efficacy with tolerability: The conversational mechanics of shared decision making in metastatic castration-resistant prostate cancer (mCRPC). Background: Dose volume specific endpoints ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback